117 related articles for article (PubMed ID: 31490767)
61. STAT signaling in the pathogenesis and treatment of myeloid malignancies.
Bar-Natan M; Nelson EA; Xiang M; Frank DA
JAKSTAT; 2012 Apr; 1(2):55-64. PubMed ID: 24058751
[TBL] [Abstract][Full Text] [Related]
62. Targeting cholesterol homeostasis in hematopoietic malignancies.
Brendolan A; Russo V
Blood; 2022 Jan; 139(2):165-176. PubMed ID: 34610110
[TBL] [Abstract][Full Text] [Related]
63. STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells.
Schepers H; Wierenga AT; Vellenga E; Schuringa JJ
JAKSTAT; 2012 Jan; 1(1):13-22. PubMed ID: 24058747
[TBL] [Abstract][Full Text] [Related]
64. Leelamine Modulates STAT5 Pathway Causing Both Autophagy and Apoptosis in Chronic Myelogenous Leukemia Cells.
Jung YY; Um JY; Chinnathambi A; Govindasamy C; Sethi G; Ahn KS
Biology (Basel); 2022 Feb; 11(3):. PubMed ID: 35336740
[TBL] [Abstract][Full Text] [Related]
65. Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice.
Sampaio LR; Dias RDB; Goes JVC; de Melo RPM; de Paula Borges D; de Lima Melo MM; de Oliveira RTG; Ribeiro-Júnior HL; Magalhães SMM; Pinheiro RF
Med Oncol; 2024 Apr; 41(6):128. PubMed ID: 38656461
[TBL] [Abstract][Full Text] [Related]
66. Profile of pacritinib and its potential in the treatment of hematologic disorders.
Hatzimichael E; Tsolas E; Briasoulis E
J Blood Med; 2014; 5():143-52. PubMed ID: 25170285
[TBL] [Abstract][Full Text] [Related]
67. LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative Neoplasms.
Salas EM; García-Barchino MJ; Labiano S; Shugay M; Pérez-Encinas M; Quinteiro C; García-Delgado M; Vizmanos JL; Novo FJ
Genes Cancer; 2011 May; 2(5):593-6. PubMed ID: 21901172
[TBL] [Abstract][Full Text] [Related]
68. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.
Maranto C; Udhane V; Jia J; Verma R; Müller-Newen G; LaViolette PS; Pereckas M; Sabharwal L; Terhune S; Pattabiraman N; Njar VCO; Imig JD; Wang L; Nevalainen MT
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217941
[TBL] [Abstract][Full Text] [Related]
69. miR-155 meets the JAK/STAT pathway.
Persson JL
Cell Cycle; 2013 Jul; 12(14):2170. PubMed ID: 23803728
[No Abstract] [Full Text] [Related]
70. Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
Wang C; Li L; Li M; Shen X; Liu Y; Wang S
Exp Cell Res; 2021 Mar; 400(1):112469. PubMed ID: 33431171
[No Abstract] [Full Text] [Related]
71. Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A; Wagner C; de Araujo ED; Bajusz D; Neubauer HA; Herling M; Gunning PT; Keserű GM; Moriggl R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817042
[TBL] [Abstract][Full Text] [Related]
72. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia.
Shahjahani M; Abroun A; Saki N; Bagher Mohammadi SM; Rezaeeyan H
Lab Med; 2020 Jul; 51(4):345-351. PubMed ID: 31860086
[TBL] [Abstract][Full Text] [Related]
73. Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
Brachet-Botineau M; Polomski M; Neubauer HA; Juen L; Hédou D; Viaud-Massuard MC; Prié G; Gouilleux F
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963765
[TBL] [Abstract][Full Text] [Related]
74. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract][Full Text] [Related]
75. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.
Wu CJ; Sundararajan V; Sheu BC; Huang RY; Wei LH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861720
[No Abstract] [Full Text] [Related]
76. Transcription factors in chimeric antigen receptor T-cell development.
Dai A; Zhang X; Wang X; Liu G; Wang Q; Yu F
Hum Cell; 2024 May; 37(3):571-581. PubMed ID: 38436882
[TBL] [Abstract][Full Text] [Related]
77. Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins.
Huang H; Liu J; Yang L; Yan Y; Chen M; Li B; Xu Z; Qin T; Qu S; Wang L; Huang G; Chen Y; Xiao Z
Blood Sci; 2023 Oct; 5(4):258-268. PubMed ID: 37941916
[TBL] [Abstract][Full Text] [Related]
78. STAT1 and Its Crucial Role in the Control of Viral Infections.
Tolomeo M; Cavalli A; Cascio A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456913
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
